GILEAD GROUP
Founded in March, 2003, the Gilead Group brings together an executive team with extensive background in the telecommunications, cable and internet industries. They leverage that experience by investing in and providing management leadership to a portfolio of Gilead Group companies.
GILEAD GROUP
Social Links:
Founded:
2003-03-01
Status:
Active
Contact:
(314) 732-4925
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-12-11 | Hookipa Pharma | Gilead Group investment in Series C - Hookipa Pharma | 60 M USD |
| 2008-05-16 | Agilis Systems | Gilead Group investment in Series B - Agilis Systems | 5 M USD |
More informations about "Gilead Group"
Gilead Sciences
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.See details»
Gilead Sciences
At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. ... We’re working with organizations in Canada and around the …See details»
Gilead Sciences - Wikipedia
In June 1987, Gilead Sciences was originally founded under the name Oligogen by Michael L. Riordan, a medical doctor. Riordan graduated from Washington University in St. Louis, the Johns Hopkins School of Medicine, and the Harvard Business School. The idea for Gilead began as a research project at Menlo Ventures, where Michael was an associate. Three scientific advisers worked …See details»
Gilead in Canada
Gilead Sciences Canada, Inc. (Gilead Canada) is the Canadian affiliate of Gilead Sciences, Inc. and was established in Ontario, in 2006. With 21 marketed products, we work in the therapeutic areas of HIV, liver disease, oncology, …See details»
Canadian Leadership Team
You are now leaving www.gilead.ca and visiting our global website, Gilead.com. Please note some of the content on this site is only intended for audiences in the United States.See details»
Board of Directors | Gilead
In partnership with the Leadership Team, the Gilead Board of Directors provides guidance to execute our mission and realize our vision of creating a healthier world for all people. …See details»
Org Chart Gilead Sciences - The Official Board
Organizational Chart of Gilead Sciences. Gilead Sciences www.gilead.com. has 109 executives and 7 subsidiaries +1 650 574 3000; Add an executive. Gilead Sciences (GILD) News . …See details»
Gilead Sciences, Inc. (GILD): history, ownership, mission, how it …
Nov 16, 2024 [relinking] Home History Owners Mission How It Works How It Makes Money Gilead Sciences, Inc. (GILD) Information A Brief History of Gilead Sciences, Inc. Company …See details»
Gilead Sciences in Canada: Pioneering Canadian …
Jun 15, 2023 Gilead Sciences Canada has established itself as a key player in the biopharmaceutical industry, well known for its involvement in creating therapies that deliver curative results in Hepatitis C, treat and prevent HIV, …See details»
Partnerships and Community - Gilead
Gilead is dedicated to developing innovative medicines for life-threatening illnesses – and we recognize that it takes more than medicine to address challenges people and communities face. That’s why we work with …See details»
Gilead Sciences, Inc. - Governance - Leadership Team
At Gilead, we promise to treat your data with respect. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any …See details»
Gilead Sciences’ Approach to Research & Drug Discovery
Our Pipeline. We have a strong and diverse pipeline, upholding our ambition, set in 2019, to deliver 10+ transformative therapies by 2030. Explore Our PipelineSee details»
Gilead Sciences, Inc. - Gilead Sciences Appoints Dietmar Berger, …
Dec 12, 2024 Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become a …See details»
Mission and Core Values - Gilead
At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 35 years, we’ve pursued the impossible, chased it down, tackled it …See details»
Meet our Leadership - Gilead Sciences
In partnership with the Board of Directors, the Gilead Leadership Team provides guidance to execute our mission and realize our vision of creating a healthier world for all people. …See details»
Gilead Sciences - Crunchbase Company Profile & Funding
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and …See details»
Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief
Dec 12, 2024 Gilead Sciences, Inc. today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become a member of Gilead’ s …See details»
Gilead Submits New Drug Application to U.S. Food and Drug ...
4 days ago In the PURPOSE 2 trial (NCT04925752), there were two HIV infections in the lenacapavir group, ... Gilead is executing an access strategy, informed by global health …See details»
Gilead Sciences - M&A Summary and Business Overview - Mergr
Gilead Sciences has acquired 24 companies, including 8 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 3 assets. Gilead Sciences’ …See details»
Careers - Gilead
Gilead is a scientific research-driven organization looking for talented individuals who are passionate about exploring the boundaries of what is possible. We are seeking people with …See details»